EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Artificial Intelligence‒Guided Phenotyping of Cardiomyopathies: From Detection to Surveillance

Evangelos K Oikonomou, Rohan Khera, Ahmad Masri

Journal of Cardiac Failure · 2026-11 · 32 (11) · 1974-1984

DOI: 10.1016/j.cardfail.2026.08.035 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cardiac Failure, 2026-11. Verfasst von Evangelos K Oikonomou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT; Cardiovascular Data Science (CarDS) Lab,…. Hauptthemen laut MEDLINE: Artificial Intelligence, Cardiomyopathies, Population Surveillance. Die Arbeit nennt 50 Literaturangaben. Gefördert von: National Heart Lung and Blood Institute, National Institute on Aging, American Heart Association Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The management of cardiomyopathies relies on timely diagnosis, precise phenotyping, multimodal risk stratification, and longitudinal monitoring. These tasks require integration of high-dimensional signals from patient history, electrocardiography, imaging, biomarkers, and longitudinal health records, data streams well-suited to artificial intelligence (AI)-enabled pattern recognition and prediction. Among inherited and acquired cardiomyopathies, hypertrophic (HCM) and transthyretin amyloid cardiomyopathy (ATTR-CM) best exemplify this opportunity. Both remain systematically underdiagnosed, span a continuous phenotypic spectrum, and are increasingly actionable through disease-modifying therapies. Emerging AI approaches applied to multimodality data streams can identify latent disease, quantify its severity, and predict its trajectory. Beyond diagnosis, AI paves the path for opportunistic screening, longitudinal surveillance, risk stratification, and novel clinical trial designs. Realizing this promise requires careful attention to label quality, generalizability, false-positive burden in low-prevalence settings, and prospective evidence that the human-AI synergy improves outcomes. In this review, we use HCM and ATTR-CM as key examples to synthesize the current evidence of AI in cardiomyopathies and propose a forward-looking framework for AI-guided disease phenotyping, with emphasis on regulation, implementation, and clinical evaluation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceCardiomyopathiesPopulation SurveillanceHumansPhenotypeCardiomyopathy, Hypertrophic

Stichwörter der Autor:innen

artificial intelligencecardiomyopathyechocardiographyelectrocardiographyhypertrophic cardiomyopathyphenotypingscreeningtransthyretin amyloidosis

Autor:innen und Institutionen

  • Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT; Cardiovascular Data Science (CarDS) Lab, Yale School of Medicine, New Haven, CT. Electronic address: evangelos…
  • Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT; Cardiovascular Data Science (CarDS) Lab, Yale School of Medicine, New Haven, CT; Section of Biomedical Informa…
  • Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR.

Förderung

  • National Heart Lung and Blood Institute
  • National Institute on Aging
  • American Heart Association Inc

Zitieren

APA

Oikonomou, E. K., Khera, R., & Masri, A. (2026). Artificial Intelligence‒Guided Phenotyping of Cardiomyopathies: From Detection to Surveillance. Journal of Cardiac Failure, 32(11), 1974-1984. https://doi.org/10.1016/j.cardfail.2026.08.035

Vancouver

Oikonomou EK, Khera R, Masri A. Artificial Intelligence‒Guided Phenotyping of Cardiomyopathies: From Detection to Surveillance. Journal of Cardiac Failure. 2026;32(11):1974-1984. doi:10.1016/j.cardfail.2026.08.035

BibTeX
@article{Oikonomou2026,
  author = {Oikonomou, Evangelos K and Khera, Rohan and Masri, Ahmad},
  title = {Artificial Intelligence‒Guided Phenotyping of Cardiomyopathies: From Detection to Surveillance},
  journal = {Journal of Cardiac Failure},
  year = {2026},
  volume = {32},
  number = {11},
  pages = {1974--1984},
  doi = {10.1016/j.cardfail.2026.08.035}
}
Kostenlos starten →